Heuser M, Smith BD, Fiedler W, Sekeres MA, et al. Correction to: Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial. Ann Hematol 2021 May 12. pii: 10.1007/s00277-021-04545.
PMID: 33978823